You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023186015
Dec 20238008
Jan 20243304
Feb 20241803
Mar 20243202
Apr 20243208
May 20243601
Jun 20242702
Jul 20242204
Aug 20243205
Sep 20243805
Oct 20243607
Nov 20242807
Dec 20241007
Jan 20252808
Feb 2025205
Mar 2025007
Apr 2025103
May 2025003
Jun 2025104
Total6420108